Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Free cash flow 2022–2025
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$385,082FY2025 · since FY2022: -$421,378 → -$385,082
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$385,082 | -5047.5% |
| FY2024 | -$7,481 | -102.1% |
| FY2023 | $359,249 | +185.3% |
| FY2022 | -$421,378 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice